BELLEVUE GROUP AG Nektar Therapeutics Transaction History

BELLEVUE GROUP AG portfolio value:

$47,000
portfolio value

BELLEVUE GROUP AG quarter portfolio value change:

-15.79%
quarter

Nektar Therapeutics 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -48.61% -14K shares -62K $3.2 14.8K
Q2 2022 share Decrease -99.40% -4.77M shares -25.80M $3.8 28.8K
Q1 2022 share Increase +8.01% 356.70K shares -34.22M $5.39 4.80M
Q4 2021 share Decrease -3.11% -142.96K shares -22.37M $14 4.45M
Q3 2021 share Increase +12.03% 493.25K shares 12.13M $17.96 4.59M
Q2 2021 share Increase +3.71% 146.8K shares -8.71M $17.16 4.10M
Q1 2021 share Increase +2.29% 88.34K shares 13.36M $20 3.95M
Q4 2020 share Increase +6.44% 233.9K shares 5.46M $17 3.86M
Q3 2020 share Increase +2.75% 97.34K shares -21.61M $16.59 3.63M
Q2 2020 share Increase +1.44% 50.3K shares 19.66M $23.16 3.53M
Q1 2020 share Increase +1.98% 67.71K shares -11.55M $17.85 3.48M
Q4 2019 share Increase +7.69% 244.11K shares 15.96M $21.59 3.41M
Q3 2019 share Increase +20.52% 540.2K shares -35.87M $18.22 3.17M
Q2 2019 share Increase +512.22% 2.20M shares 79.22M $35.58 2.63M
Q1 2019 share Increase +64.63% 168.81K shares 5.86M $33.6 430.02K
Q4 2018 share Increase +370.48% 205.69K shares 5.20M $32.87 261.21K
Q3 2018 share Increase +60.93% 21.02K shares 1.69M $60.96 55.52K
Q2 2018 share Decrease -2.82% -1K shares -2.08M $48.83 34.5K
Q1 2018 share Decrease -52.48% -39.2K shares -689K $106.26 35.5K
Q4 2017 share Decrease -39.27% -48.3K shares 1.50M $59.72 74.7K
Q3 2017 share Increase +186.05% 80K shares 2.11M $24 123K
Q2 2017 share Decrease -75.00% -129K shares -3.19M $19.55 43K
Q1 2017 share Decrease -7.53% -14K shares 1.75M $23.47 172K
Q4 2016 share 0.00% 0 shares -913K $12.27 186K
Q3 2016 share 0.00% 0 shares 548K $17.18 186K
Q2 2016 share Decrease -13.89% -30K shares -323K $14.23 186K
Q1 2016 share Increase 0.00% 216K shares 2.97M $13.75 216K